Seeking Alpha

Valeant Pharmaceuticals (VRX) raised its offer for ISTA Pharmaceuticals (ISTA) to $7.50/share...

Valeant Pharmaceuticals (VRX) raised its offer for ISTA Pharmaceuticals (ISTA) to $7.50/share from an initial $6.50/share, and set a target price of $8.50/share subject to a week of due diligence, according to an ISTA statement. ISTA officials say they're considering the revised offer but are also in talks with other companies. (previously)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|